Pushing the Limits of Medical Management in HCM: A Review of Current Pharmacological Therapy Options

Hypertrophic cardiomyopathy (HCM) is the most common monogenic cardiac disease with a highly variable phenotypic expression, ranging from asymptomatic to drug refractory heart failure (HF) presentation. Pharmacological therapy is the first line of treatment, but options are currently limited to nons...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Stătescu, Cristian, Enachi, Ștefana, Ureche, Carina, Țăpoi, Laura, Anghel, Larisa, Șalaru, Delia, Pleșoianu, Carmen, Bostan, Mădălina, Marcu, Dragoș, Ovanez Balasanian, Mircea, Sascău, Radu Andy
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8268685/
https://ncbi.nlm.nih.gov/pubmed/34281272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22137218
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados